Cronos (CRON) Cash & Equivalents (2016 - 2026)
Cronos (CRON) posted quarterly Cash & Equivalents of $821.9 million for Q1 2026, up 3.01% year-over-year from $797.8 million in Q1 2025, and up 3.8% quarter-over-quarter from $791.8 million in Q4 2025.
Cronos (CRON) Cash & Equivalents (2016 - 2026) Analysis & Trends
Cronos' Cash & Equivalents history runs 11 years deep, the most recent figure standing at $821.9 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 3.01% year-over-year to $821.9 million; the TTM figure through Mar 2026 stood at $821.9 million (up 3.01% YoY), while the FY2025 annual figure was $791.8 million, down 7.8% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $821.9 million, up from $791.8 million in the prior quarter.
- The five-year high for Cash & Equivalents was $862.0 million in Q3 2024, with the low at $409.4 million in Q2 2023.
- The 5-year median for Cash & Equivalents is $791.8 million (2025), against an average of $736.9 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents sank 51.98% in 2023, then jumped 107.16% in 2024.
- Cronos' Cash & Equivalents stood at $764.6 million in 2022, then declined by 12.47% to $669.3 million in 2023, then gained by 28.32% to $858.8 million in 2024, then retreated by 7.8% to $791.8 million in 2025, then climbed by 3.8% to $821.9 million in 2026.
- Business Quant data shows CRON's Cash & Equivalents at $821.9 million in Q1 2026, $791.8 million in Q4 2025, and $784.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | 467.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 467.02 Mn |
| Mar 31, 2026 | 821.86 Mn |
| Dec 31, 2025 | 791.79 Mn |
| Sep 30, 2025 | 784.17 Mn |
| Jun 30, 2025 | 794.42 Mn |
| Mar 31, 2025 | 797.82 Mn |
| Dec 31, 2024 | 858.81 Mn |
| Sep 30, 2024 | 862.03 Mn |
| Jun 30, 2024 | 848.19 Mn |
| Mar 31, 2024 | 855.11 Mn |
| Dec 31, 2023 | 669.29 Mn |
| Sep 30, 2023 | 571.66 Mn |
| Jun 30, 2023 | 409.43 Mn |
| Mar 31, 2023 | 413.67 Mn |
| Dec 31, 2022 | 764.64 Mn |
| Sep 30, 2022 | 633.30 Mn |
| Jun 30, 2022 | 789.54 Mn |
| Mar 31, 2022 | 861.54 Mn |
| Dec 31, 2021 | 886.97 Mn |
| Sep 30, 2021 | 842.57 Mn |